Insulin resistance as a modifiable contributor to breast cancer: mechanisms, biomarkers, and therapeutic implications.
Saved in:
| Title: | Insulin resistance as a modifiable contributor to breast cancer: mechanisms, biomarkers, and therapeutic implications. |
|---|---|
| Authors: | Marouf SP; School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.; Universal Scientific Education and Research Network (USERN), Tehran, Iran., Meskar Z; Universal Scientific Education and Research Network (USERN), Tehran, Iran.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran., Rezaei N; Universal Scientific Education and Research Network (USERN), Tehran, Iran. rezaei_nima@tums.ac.ir.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.; Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. rezaei_nima@tums.ac.ir.; Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Dr. Qarib St, Keshavarz Blvd, Tehran, 14194, Iran. rezaei_nima@tums.ac.ir. |
| Source: | Discover oncology [Discov Oncol] 2026 Mar 22; Vol. 17 (1). Date of Electronic Publication: 2026 Mar 22. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-04828-1 |
